HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.

AbstractOBJECTIVE:
To assess patient satisfaction with vertigo control using intratympanic (IT) dexamethasone (12 mg/mL) for medically refractory unilateral Ménière's disease.
STUDY DESIGN:
Retrospective study.
SETTING:
Tertiary referral neurotology clinic.
PATIENTS:
One hundred twenty-nine subjects diagnosed with unilateral Ménière's disease still having vertigo despite medical therapy.
INTERVENTION:
IT dexamethasone injections as needed to control vertigo attacks.
MAIN OUTCOME MEASURE:
A Kaplan-Meier time-to-event method was used to determine the rate of "survival," meaning sufficient satisfaction with vertigo control that the subject did not wish to have subsequent ablative treatment. "Failure" was defined as poor control and the choice to proceed to ablative treatment.
RESULTS:
Acceptable vertigo control ("survival") was achieved in 117 (91%) of 129 subjects. Vertigo control required only one dexamethasone injection in 48 (37%), 2 injections in 26 (20%), 3 injections in 18 (14%), and 4 injections in 10 (8%). More than 4 injections were needed in 15 subjects (21%). Of 12 failures (9%), 9 occurred within 6 months of the first IT dexamethasone injection. Follow-up data for 2 years were available for 96 subjects. Of these, 87 (91%) had vertigo control with IT dexamethasone, of whom 61 (70)% required no further injections after 2 years, 23 (26%) continued to receive IT dexamethasone injections, and 3 (3%) chose IT gentamicin treatment.
CONCLUSION:
IT dexamethasone injection therapy on an as-needed outpatient basis can provide vertigo control that is satisfactory in patients with Ménière's disease. The Kaplan-Meier method addresses the need for an outcome measure suited to repeated treatments and variable lengths of follow-up. However, due to the retrospective nature of this study, the presence of bias caused by loss of subjects from follow-up cannot be ruled out.
AuthorsMaria Soledad Boleas-Aguirre, Frank R Lin, Charles C Della Santina, Lloyd B Minor, John P Carey
JournalOtology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (Otol Neurotol) Vol. 29 Issue 1 Pg. 33-8 (Jan 2008) ISSN: 1531-7129 [Print] United States
PMID18199956 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Gentamicins
  • Dexamethasone
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Anti-Inflammatory Agents (administration & dosage, therapeutic use)
  • Audiometry
  • Dexamethasone (administration & dosage, therapeutic use)
  • Drug Resistance
  • Follow-Up Studies
  • Gentamicins (therapeutic use)
  • Humans
  • Injections
  • Longitudinal Studies
  • Meniere Disease (drug therapy)
  • Retrospective Studies
  • Survival Analysis
  • Treatment Failure
  • Treatment Outcome
  • Tympanic Membrane

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: